Novo Nordisk announces plans to cut 9,000 jobs amid rising competition and profit warnings in the obesity drug market, focusing resources on growth sectors.
A new poll reveals that while many Americans support weight-loss drugs for adults, opinions are split regarding their use among teens battling obesity.